Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Cheng

Showing results (91-100 of 156) with videos related to

Pageof 16
Sort By:
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 31, 2021
Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysisJulien Senécal, Elizabeth Smyth, Olivier Del Corpo, et al.
The Lancet. Infectious Diseases|August 9, 2020
SeroTracker: a global SARS-CoV-2 seroprevalence dashboardRahul K Arora, Abel Joseph, Jordan Van Wyk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2019
Risk of Latent Tuberculosis Reactivation After Hematopoietic cell TransplantationMatthew P Cheng, Amanda E Kusztos, Tyler D Bold, et al.
Microbiology Spectrum|September 30, 2025
The combinations of cefazolin with linezolid and cefazolin with clindamycin are indifferent against methicillin-susceptible <i>Staphylococcus aureus</i>Madeline Mellett, Julia Van Riel, Rachel Corsini, et al.
Journal of Clinical Microbiology|October 20, 2021
Specificity of SARS-CoV-2 Antibody Detection Assays against S and N Proteins among Pre-COVID-19 Sera from Patients with Protozoan and Helminth Parasitic InfectionsCedric P Yansouni, Jesse Papenburg, Matthew P Cheng, et al.
Annals of Internal Medicine|June 5, 2020
Serodiagnostics for Severe Acute Respiratory Syndrome-Related Coronavirus 2 : A Narrative ReviewMatthew P Cheng, Cedric P Yansouni, Nicole E Basta, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 18, 2021
Cytomegalovirus events in high-risk allogeneic hematopoietic-cell transplantation patients who received letermovir prophylaxisKaiwen Chen, Esther Arbona-Haddad, Matthew P Cheng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2025
Patient-reported perceptions, experiences and preferences around intravenous and oral antibiotics for the treatment of Staphylococcus aureus bacteremia: a descriptive qualitative studyGenevieve Walls, Loughlin McGrath, Michael Trent Herdman, et al.
BMJ Open|February 9, 2021
Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)Roni Bitterman, Fidi Koppel, Cristina Mussini, et al.
British Journal of Haematology|November 22, 2018
Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinibMatthew P Cheng, Amanda E Kusztos, Joshua N Gustine, et al.
Pageof 16

Showing results (91-100 of 156) with videos related to

Sort By:
Pageof 16
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|August 31, 2021
Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysisJulien Senécal, Elizabeth Smyth, Olivier Del Corpo, et al.
The Lancet. Infectious Diseases|August 9, 2020
SeroTracker: a global SARS-CoV-2 seroprevalence dashboardRahul K Arora, Abel Joseph, Jordan Van Wyk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 29, 2019
Risk of Latent Tuberculosis Reactivation After Hematopoietic cell TransplantationMatthew P Cheng, Amanda E Kusztos, Tyler D Bold, et al.
Microbiology Spectrum|September 30, 2025
The combinations of cefazolin with linezolid and cefazolin with clindamycin are indifferent against methicillin-susceptible <i>Staphylococcus aureus</i>Madeline Mellett, Julia Van Riel, Rachel Corsini, et al.
Journal of Clinical Microbiology|October 20, 2021
Specificity of SARS-CoV-2 Antibody Detection Assays against S and N Proteins among Pre-COVID-19 Sera from Patients with Protozoan and Helminth Parasitic InfectionsCedric P Yansouni, Jesse Papenburg, Matthew P Cheng, et al.
Annals of Internal Medicine|June 5, 2020
Serodiagnostics for Severe Acute Respiratory Syndrome-Related Coronavirus 2 : A Narrative ReviewMatthew P Cheng, Cedric P Yansouni, Nicole E Basta, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 18, 2021
Cytomegalovirus events in high-risk allogeneic hematopoietic-cell transplantation patients who received letermovir prophylaxisKaiwen Chen, Esther Arbona-Haddad, Matthew P Cheng, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 24, 2025
Patient-reported perceptions, experiences and preferences around intravenous and oral antibiotics for the treatment of Staphylococcus aureus bacteremia: a descriptive qualitative studyGenevieve Walls, Loughlin McGrath, Michael Trent Herdman, et al.
BMJ Open|February 9, 2021
Piperacillin-tazobactam versus meropenem for treatment of bloodstream infections caused by third-generation cephalosporin-resistant Enterobacteriaceae: a study protocol for a non-inferiority open-label randomised controlled trial (PeterPen)Roni Bitterman, Fidi Koppel, Cristina Mussini, et al.
British Journal of Haematology|November 22, 2018
Low risk of Pneumocystis jirovecii pneumonia and invasive aspergillosis in patients with Waldenström macroglobulinaemia on ibrutinibMatthew P Cheng, Amanda E Kusztos, Joshua N Gustine, et al.
Pageof 16